- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/72 - ReceptorsCell surface antigensCell surface determinants for hormones
Patent holdings for IPC class C07K 14/72
Total number of patents in this class: 1014
10-year publication summary
|
79
|
77
|
94
|
79
|
75
|
81
|
75
|
66
|
69
|
36
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1126 |
38 |
| The Regents of the University of California | 20778 |
20 |
| Vib VZW | 908 |
18 |
| Vrije Universiteit Brussel | 531 |
18 |
| Regeneron Pharmaceuticals, Inc. | 4727 |
17 |
| The Board of Trustees of the Leland Stanford Junior University | 6656 |
13 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2304 |
13 |
| Nxera Pharma UK Limited | 185 |
13 |
| Massachusetts Institute of Technology | 10254 |
12 |
| Rhythm Pharmaceuticals, Inc. | 95 |
12 |
| Amgen Inc. | 4429 |
10 |
| President and Fellows of Harvard College | 6092 |
10 |
| Duke University | 3182 |
10 |
| Hanmi Pharm. Co., Ltd. | 602 |
10 |
| Heptares Therapeutics Limited | 73 |
10 |
| Board of Regents, The University of Texas System | 6117 |
9 |
| Cornell University | 3426 |
9 |
| H. Lundbeck A/S | 1232 |
9 |
| Asterion Limited | 21 |
8 |
| Centre National de La Recherche Scientifique | 11026 |
7 |
| Other owners | 748 |